Document is current

Article History

Accepted: 30 September 2024

First Online: 4 November 2024

Declarations

:

: No external funding was used in the preparation of this article.

: <i>Dr. Banach</i> has received research grant(s)/support from Amgen, Daiichi-Sankyo, Mylan/Viatris, and Sanofi, and has received honoraria and/or served as a consultant for Adamed, Amgen, Daiichi-Sankyo, Esperion, Kogen, KRKA, Lilly, MSD, Mylan/Viatris, NewAmsterdam Pharma, Novartis, Novo Nordisk, Polfarmex, Polpharma, Sanofi-Regeneron, Servier, Teva, and Zentiva. <i>Dr. Reiner</i> has received honoraria from Sanofi and Novartis. <i>Dr. Cicero</i> has received personal fees from Mylan-Viatris, Sharper, and Servier. <i>Dr. Dyrbuś</i> has received fee for scientific activities from Novartis, Sanofi-Aventis, and Amgen. <i>Dr. Fedacko</i> has received a consultancy fee from Sanofi, Amgen and Novo Nordisk, and a research grant from Pfizer. <i>Dr. Fras</i> has received grants and fees for scientific activities from Amgen, Krka, Novartis, Swix BioPharma, and Viatris. <i>Dr. Gaita</i> has received honoraria from Amgen, AstraZeneca, Bayer, Berlin Chemie, Biofarm, Boehringer Ingelheim, Galenica, GSK, Gedeon Richter, Krka, MSD, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Terapia, Vifor Pharma, and Zentiva. <i>Dr. Gierlotka</i> reports honoraria from Sanofi, Novartis, Bayer, Amgen, Novo Nordisk, AstraZeneca, Servier. <i>Dr. Gouni-Berthold</i> has served as consultant and received honoraria from Akcea, Amgen, Daiichi-Sankyo, Novartis, Sanofi-Regeneron, Ultragenyx, and Amarin. <i>Dr. Jankowski</i> has received a research grant from Sanofi and has served as a consultant for Novartis, Servier, and Zentiva. <i>Dr. Járai</i> has served as a consultant for and received honoraria from Bayer, Berlin-Chemie, Boehringer Ingelheim, Egis, MSD, Novartis (Sandoz), Novo Nordisk, Pfizer, Richter Gedeon, Sanofi, Servier, and Teva. <i>Dr. Latkovskis</i> has given talks, attended conferences, received consultancy fees, and/or participated in trials sponsored by Abbott Laboratories, Amgen, AstraZeneca, Berlin-Chemie/Menarini, Bayer, Boehringer Ingelheim, GlaxoSmithKline, Grindex, KRKA, MSD, Mylan, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier Laboratories, Siemens Laboratories, and Zentiva. <i>Dr. Magda</i> has received consultation fees from Novartis, Sanofi, and Servier. <i>Dr. Margetic</i> has received a fee for scientific activities from Novartis and Sanofi. <i>Dr. Ostadal</i> has received honoraria from Getinge, Abiomed, Edwards, Fresenius/Xenios, AstraZeneca, Bayer, Boehringer Ingelheim, Amgen, Sanofi, Servier, Novartis, Pfizer, AOP, and GSK. <i>Dr Paragh</i> has received lectures fees from Hungarian branches of Novartis, Richter Gedeon, and Sandoz. <i>Dr. Paneni</i> has received honoraria from Novo Nordisk. <i>Dr. Pećin</i> has received grants and fees for scientific activities from Amgen, Bayer, Novartis, and Sanofi. <i>Dr. Pella</i> has received grant support and honoraria from Sanofi, Amgen, MSD, Servier, Novartis, and Pfizer. <i>Dr. Postadzhiyan</i> reports fees for educational activities from Amgen, AstraZeneca, KRKA, Novartis, Servier, Teva, and Zentiva. <i>Dr. Stoian</i> has given lectures, received honoraria and research support, and participated in conferences, advisory boards, and clinical trials sponsored by pharmaceutical companies, from AstraZeneca, Amgen, Boehringer Ingelheim, Coca-Cola, Eli Lilly, Merck, Medtronic, MSD, Medochemie, Novo Nordisk, Novartis, Roche Diagnostics, Servier, Sandoz, and Sanofi. <i>Dr. Trbusic</i> has received a fee for scientific activities from Novartis and Sanofi. <i>Dr. Udroiu</i> has received a fee for scientific activities from AstraZeneca and Pfizer. <i>Dr. Viigimaa</i> reports fees for educational activities from Amgen, AstraZeneca, Novartis, Novo Nordisk, Menarini, Servier, and Swixx BioPharma. <i>Dr. Vinereanu</i> has received research grants and expert fees from Amgen, Sanofi, Novartis, and Servier. <i>Dr. Vlachopoulos</i> has received grants and fees for scientific activities from Amgen, Sanofi, and MSD. <i>Dr. Vrablik</i> has received personal fees from Abbott, Amgen, AstraZeneca, BMS, Genzyme, KRKA, MSD Idea, Novartis, Pfizer, and Sanofi-Regeneron. <i>Dr. Vulic</i> has received a fee for scientific activities from Sanofi. <i>Dr. Penson</i> owns four shares in AstraZeneca PLC and has received honoraria from Amgen and Sanofi and travel/accommodation reimbursement for events sponsored by AKCEA, Amgen, AMRYT, Link Medical, Mylan, and Napp. <i>All other authors</i> declare that they have no potential conflicts of interest that might be relevant to the contents of this article.

: <i>Dr. Banach:</i> Conceptualisation; data curation; methodology; project administration; supervision; validation; visualisation; writing, reviewing, and editing; revisions; preparing the final version of the paper. <i>Dr. Penson:</i> Data curation; investigation; methodology; validation; visualisation; first draft preparation; reviewing and editing. <i>Dr Surma:</i> data curation, visualisation, draft figures preparations; reviewing and editing. <i>Drs. Reiner, Bajraktari, Bielecka-Dabrowa, Bunc, Bytyçi, Ceska, Cicero, Dudek, Dyrbuś, Fedacko, Fras, Gaita, Gavish, Gierlotka, Gil, Gouni-Berthold, Jankowski, Járai, Jóźwiak, Katsiki, Latkovskis, Magda, Margetic, Margoczy, Mitchenko, Durak-Nalbantic, Ostadal, Paragh, Petrulioniene, Paneni, Pećin, Pella, Postadzhiyan, Stoian, Trbusic, Udroiu, Viigimaa, Vinereanu, Vlachopoulos, Vrablik</i>, and <i>Vulic</i>: Investigation, methodology; validation; writing, reviewing, and editing; final revisions and approval.

: Data sharing is not applicable to this article as no datasets were generated for this article.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.